MOUNTAIN VIEW, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method available*, today released a new data report on Essure's 10-year commercial success at the 40th AAGL Global Congress of Minimally Invasive Gynecology in Hollywood, Florida, November 7-10, 2011.
